The Week In Crunchbase Data: Billions Raised In 2022 Still Fall Short

The Week In Crunchbase Data: Billions Raised In 2022 Still Fall Short

Time Stamp: January 5, 2023 3:40 PM
Source Node: 1869520

Welcome to the unofficial forecast edition of the Crunchbase Data Digest. While 2022’s funding numbers couldn’t hope to live up to the previous year’s incredible run, they still looked better than 2020’s pandemic swoon.

Search less. Close more.

Grow your revenue with all-in-one prospecting solutions powered by the leader in private-company data.

But what goes up must come down (check out our layoff tracker for evidence of that), and 2023 is already showing nervous signs that venture funding hasn’t hit the floor yet.

Illustration: Dom Guzman

Stay up to date with recent funding rounds, acquisitions, and more with the Crunchbase Daily.

Venture and growth investors in private companies scaled back their investment pace significantly in the latter half of 2022, signaling a slower…

SpaceX, Elon Musk’s rocket and satellite company, aims to raise a fresh $750 million round at a $137 billion valuation, according to reports.

The “omics” — genomics, transcriptomics, metabolomics and proteomics — are booming in biotech, with more big raises expected in 2023.

Dealmakers think 2023 could see a significant jump in M&A volume as companies’ options for money and exits dwindle.

Time Stamp:

More from Crunchbase News